Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
1 result
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Omalizumab in Chronic Spontaneous Urticaria (CSU): Real-Life Experience in Dose/Interval Adjustments and Treatment Discontinuation.
J Allergy Clin Immunol Pract. 2023 Aug;11(8):2392-2402. doi: 10.1016/j.jaip.2023.01.022. Epub 2023 Jan 28.
J Allergy Clin Immunol Pract. 2023.
PMID: 36720390
Cite
Cite